ABVC Biopharma Inc (ABVC)

Currency in USD
2.7500
+0.3500(+14.58%)
Closed·
After Hours
2.7000-0.0500(-1.82%)
·
ABVC Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
ABVC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.39002.7700
52 wk Range
0.40005.4800
Key Statistics
Prev. Close
2.75
Open
2.39
Day's Range
2.39-2.77
52 wk Range
0.4-5.48
Volume
320K
Average Volume (3m)
443.49K
1-Year Change
281.94%
Book Value / Share
0.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABVC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

ABVC Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

ABVC Biopharma Inc Company Profile

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is headquartered in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

Compare ABVC to Peers and Sector

Metrics to compare
ABVC
Peers
Sector
Relationship
P/E Ratio
−15.4x−1.5x−0.5x
PEG Ratio
−0.18−0.030.00
Price/Book
8.3x1.6x2.6x
Price / LTM Sales
87.9x10.2x3.3x
Upside (Analyst Target)
-316.7%45.1%
Fair Value Upside
Unlock36.7%7.4%Unlock

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ABVC Income Statement

People Also Watch

31.68
BMNR
-8.55%
0.92
KLTO
-4.15%
2.200
ONDS
+3.77%
7.570
TRON
-10.73%
52.460
ASTS
-1.34%

FAQ

What Stock Exchange Does ABVC Biopharma Trade On?

ABVC Biopharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ABVC Biopharma?

The stock symbol for ABVC Biopharma is "ABVC."

What Is the ABVC Biopharma Market Cap?

As of today, ABVC Biopharma market cap is 44.69M.

What Is ABVC Biopharma's Earnings Per Share (TTM)?

The ABVC Biopharma EPS (TTM) is -0.22.

From a Technical Analysis Perspective, Is ABVC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has ABVC Biopharma Stock Split?

ABVC Biopharma has split 3 times.

How Many Employees Does ABVC Biopharma Have?

ABVC Biopharma has 18 employees.

What is the current trading status of ABVC Biopharma (ABVC)?

As of 04 Aug 2025, ABVC Biopharma (ABVC) is trading at a price of 2.75, with a previous close of 2.75. The stock has fluctuated within a day range of 2.39 to 2.77, while its 52-week range spans from 0.40 to 5.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.